Immunotherapies have become essential in treating advanced malignancies. However, immunotherapies can attack healthy cells, leading to toxicities or side effects.
To address how to best treat patients with these toxicities, the Internal Medicine division has collaborated with the Cancer Medicine division, as well as other divisions at MD Anderson, to create the Immuno-Oncology Toxicity (IOTOX) Leaders Group.
Clinical management algorithms depict best practices for evaluating, diagnosing, and treating specific conditions that arise during the course of cancer treatment. These algorithms are not intended to replace the independent medical judgment of the physician in the context of individual clinical circumstances to determine a patient's care.
评分及评论
此 App 尚未收到足够的评分或评论,无法显示整体评分。
Improvements to better support accessibility.
版本 1.1
开发者“MD Anderson Cancer Center”已表明该 App 的隐私规范可能包括下述数据处理方式。更多相关信息,请参阅 开发者隐私政策 。